Abstract:It is known that metabolic syndrome is a risk factor of myocardial infarction and cerebrovascular disorder. Rats fed a high fat diet have been used as an animal model of metabolic syndrome, i.e., increases in body mass, arterial pressure (AP), and leptin in plasma. We hypothesized that sympathoexcitation caused by the elevated orexin sensitivity in rostral ventrolateral medulla (RVLM) induces an increased AP in HFD. We employed Sprague Dawley rats fed a high fat diet (HFD) or a normal diet (ND) for 10 weeks from 3 weeks old. We measured orexin A in cerebrospinal fluid by ELISA and orexin receptors (OX1R, OX2R) mRNA expression in RVLM by RT‐PCR. There was no significant difference in orexin A between HFD and ND (HFD: 62.5 ± 2.1 pg/mL, ND: 58.1 ± 3.0 pg/mL). On the other hand, OX2R mRNA in HFD was significantly higher than that in ND (HFD: 0.98 ± 0.21, ND: 0.50 ± 0.10). To test the hypothesis, we injected orexin B (175 pmol in 50 nL) to RVLM under urethane + α‐chloralose anesthesia with measuring AP. Orexin B induced a larger AP response in HFD than ND (area under the curve in HFD: 1675 ± 318 mmHg·180 s, ND: 814 ± 255 mmHg·180 s). We also injected OX2R antagonist, TCS‐OX2‐29 (20 nmol in 2 μL) to the lateral ventricle. Although OX2R antagonist had no effect on AP in ND, it decreased AP in HFD (area under the curve in HFD: − 509 ± 113 mmHg·180 s, ND: 171 ± 50 mmHg·180 s). These results suggested that the elevated orexin sensitivity in RVLM induces a chronic increased AP in HFD. To further examine this, whether AP in HFD is decreased by chronic injection of OX2R antagonist has to be determined in a future study.

Relationship between the elevated orexin sensitivity via OX2R in RVLM and an increased arterial pressure in rats fed a high fat diet